D.E. Shaw buys more shares of Endo Pharmaceuticals

By Lisa Kerner

Charlotte, N.C., Nov. 21 - Affiliates of D.E. Shaw Composite International Fund increased their ownership of Endo Pharmaceuticals Holdings Inc. to 8.4% from 7.3%, according to a schedule 13D filing with the Securities and Exchange Commission.

The investors bought a total of 1,560,054 shares between Oct. 12 and Nov. 20 priced from $27.79 to $40.00 per share. The investors now own 11,286,836 shares of Endo.

Endo is a pharmaceutical company based in Chadds Ford, Pa.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.